title: A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
authors.affiliation: Digestive Disease Research Center, Medical Science/University of Tehran, Shariati Hospital, Kargar Shomali Ave, Tehran, Iran.
authors.forename: Mansoor
authors.initials: M
authors.lastname: Rastegarpanah
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Malekzadeh
authors.forename: G Neil
authors.initials: GN
authors.lastname: Thomas
authors.forename: Abbas
authors.initials: A
authors.lastname: Mohagheghi
authors.forename: K K
authors.initials: KK
authors.lastname: Cheng
authors.forename: Tom
authors.initials: T
authors.lastname: Marshall
mesh_terms: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin